Kyowa Kirin Co., Ltd. (TYO:4151)
Japan · Delayed Price · Currency is JPY 2,885.00
+72.50 (2.58%)
At close: Feb 27, 2026
Kyowa Kirin Market Cap
Kyowa Kirin has a market cap or net worth of 1.51 trillion as of February 27, 2026. Its market cap has increased by 27.90% in one year.
Market Cap
1.51T
Enterprise Value
1.29T
Revenue
496.83B
Ranking
n/a
PE Ratio
22.53
Stock Price
2,885.00
Market Cap Chart
Since May 6, 1994, Kyowa Kirin's market cap has increased from 435.63B to 1.51T, an increase of 246.68%. That is a compound annual growth rate of 3.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 1.51T | 14.17% |
| Dec 30, 2025 | 1.32T | 9.41% |
| Dec 30, 2024 | 1.21T | -5.11% |
| Dec 29, 2023 | 1.27T | -21.50% |
| Dec 30, 2022 | 1.62T | -3.64% |
| Dec 30, 2021 | 1.68T | 11.44% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Chugai Pharmaceutical | 16.94T |
| Daiichi Sankyo Company | 5.64T |
| Otsuka Holdings | 5.49T |
| Astellas Pharma | 4.54T |
| Ono Pharmaceutical | 1.23T |
| Santen Pharmaceutical | 564.05B |
| JCR Pharmaceuticals | 82.83B |
| Perseus Proteomics | 3.32B |